Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1997 Dec;167(6):417–419.

Mad cow disease. An opportunity for preventive medicine?

P Salzmann 1, S Saint 1, L M Tierney Jr 1
PMCID: PMC1304721  PMID: 9426481

Full text

PDF
417

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beardsley T. Deadly enigma. The U.S. wakes up to the threat of mad cow disease and its relatives. Sci Am. 1996 Dec;275(6):16–18. [PubMed] [Google Scholar]
  2. Bovine spongiform encephalopathy: "mad cow disease". Nutr Rev. 1996 Jul;54(7):208–210. doi: 10.1111/j.1753-4887.1996.tb03934.x. [DOI] [PubMed] [Google Scholar]
  3. Brown P. The risk of bovine spongiform encephalopathy ('mad cow disease') to human health. JAMA. 1997 Sep 24;278(12):1008–1011. [PubMed] [Google Scholar]
  4. Detsky A. S., Naglie I. G. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990 Jul 15;113(2):147–154. doi: 10.7326/0003-4819-113-2-147. [DOI] [PubMed] [Google Scholar]
  5. Gage B. F., Cardinalli A. B., Albers G. W., Owens D. K. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995 Dec 20;274(23):1839–1845. [PubMed] [Google Scholar]
  6. Goldman L., Gordon D. J., Rifkind B. M., Hulley S. B., Detsky A. S., Goodman D. W., Kinosian B., Weinstein M. C. Cost and health implications of cholesterol lowering. Circulation. 1992 May;85(5):1960–1968. doi: 10.1161/01.cir.85.5.1960. [DOI] [PubMed] [Google Scholar]
  7. Goldman L., Weinstein M. C., Goldman P. A., Williams L. W. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991 Mar 6;265(9):1145–1151. [PubMed] [Google Scholar]
  8. Holman R. C., Khan A. S., Belay E. D., Schonberger L. B. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis. 1996 Oct-Dec;2(4):333–337. doi: 10.3201/eid0204.960409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holman R. C., Khan A. S., Kent J., Strine T. W., Schonberger L. B. Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology. 1995;14(4):174–181. doi: 10.1159/000109793. [DOI] [PubMed] [Google Scholar]
  10. Kimberlin R. H., Wilesmith J. W. Bovine spongiform encephalopathy. Epidemiology, low dose exposure and risks. Ann N Y Acad Sci. 1994 Jun 6;724:210–220. doi: 10.1111/j.1749-6632.1994.tb38911.x. [DOI] [PubMed] [Google Scholar]
  11. Marwick C. Views of reason for mad cow disease vary widely. JAMA. 1996 Aug 14;276(6):438–440. [PubMed] [Google Scholar]
  12. Pauker S. G. Deciding about screening. Ann Intern Med. 1993 Jun 1;118(11):901–902. doi: 10.7326/0003-4819-118-11-199306010-00013. [DOI] [PubMed] [Google Scholar]
  13. Russell L. B., Gold M. R., Siegel J. E., Daniels N., Weinstein M. C. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 9;276(14):1172–1177. [PubMed] [Google Scholar]
  14. Wilesmith J. W. An epidemiologist's view of bovine spongiform encephalopathy. Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):357–361. doi: 10.1098/rstb.1994.0029. [DOI] [PubMed] [Google Scholar]
  15. Will R. G., Ironside J. W., Zeidler M., Cousens S. N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P. G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996 Apr 6;347(9006):921–925. doi: 10.1016/s0140-6736(96)91412-9. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES